August 29, 2014 12:05 PM ET

Biotechnology

Company Overview of OPKO Biologics

Executive Profile

Fuad Fares D.Sc.

Director and Chief Scientific Officer of Prolor Biotech Ltd, OPKO Biologics
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 1 different industries.

See Board Relationships
59--

Background

Dr. Fuad Fares , DSc is an Enterpreneur and has been Chief Scientific Officer at Modigene, Inc at OPKO Biologics since 2002. Dr. Fares has been the Head of the Molecular Biology Division, Biochemical Research Unit, Department of Biochemistry, and Molecular Genetics at the Carmel Medical Center in Haifa, Israel, and has been the Managing Director at Galili Herbal since 1999. He has been a Director of Modigene, Inc. since May 2007 and a Director of Modigene Delaware since ...

Corporate Headquarters

7 Golda Meir Street
Nes-Ziona, -- 74140

Israel

Phone: 866 644 7811
Fax: 972 8 930 0091

Board Members Memberships

2007-Present
Director and Chief Scientific Officer of Prolor Biotech Ltd

Education

Unknown/Other Education
Technion Israel Institute Of Technology

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OPKO Biologics, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.